Alexander V. Gasparian

Author

Cleveland BioLabs (United States)

Also Known As

Alexander Gasparian, Alexander V Gasparian, Alexander V. Gasparian, Alexander V. Gasparian

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Cleveland BioLabs (United States)Roswell Park Comprehensive Cancer Center Russian Cancer Research Center NN Blokhin Cleveland Clinic University of South Carolina

About

Alexander V. Gasparian is an author at Cleveland BioLabs (United States) specializing in medicine, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	228
2	Engineering	1	1	13
3	Health Sciences	1	1	30
4	Natural Sciences	1	1	37
5	Allergy	1	1	31

Alexander V. Gasparian

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Core circadian protein CLOCK is a positive regulator of NF-κB–mediated transcription Mary L. Spengler, Karen K. Kuropatwinski, Maria Comas, Proceedings of the National Academy of Sciences	2012	307
The role of IKK in constitutive activation of NF-κB transcription factor in prostate carcinoma cells Alexander V. Gasparian, Ya Juan Yao, Dariusz Kowalczyk, Journal of Cell Science	2002	273
Curaxins: Anticancer Compounds That Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT Alexander V. Gasparian, Catherine A. Burkhart, Andrei A. Purmal, Science Translational Medicine	2011	236
Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells. Alexander V. Gasparian, Ya Juan Yao, Junxuan Lü, PubMed Tumor BiologySelenium CompoundsUrologyChemoprevention StrategyMedicine	2002	97
Anti-malaria drug blocks proteotoxic stress response: Anti-cancer implications Nickolay Neznanov, Anton V. Gorbachev, Lubov Neznanova, Cell Cycle	2009	59
Identification of novel cancer therapeutic targets using a designed and pooled shRNA library screen David J. Oliver, Hao Ji, Piaomu Liu, Scientific Reports	2017	45
Targeting transcription factor NFκB: comparative analysis of proteasome and IKK inhibitors Alexander V. Gasparian, Olga A. Guryanova, Dmitry V. Chebotaev, Cell Cycle	2009	44
Inhibition of Encephalomyocarditis Virus and Poliovirus Replication by Quinacrine: Implications for the Design and Discovery of Novel Antiviral Drugs Alexander V. Gasparian, Nickolay Neznanov, Sujata Jha, Journal of Virology Viral ReplicationQc IntercalationImmunologyMolecular BiologyPharmacotherapy	2010	37
Quinacrine inhibits the epidermal dendritic cell migration initiating T cell‐mediated skin inflammation Anton V. Gorbachev, Alexander V. Gasparian, Katerina V. Gurova, European Journal of Immunology ImmunologySkin AllergyDermatologyImmunotherapyHypersensitivity	2007	31
Somatic genetic alterations (loh) in benign, borderline and invasive ovarian tumours: Intratumoral molecular heterogeneity I. B. Zborovskaya, Alexander V. Gasparian, Appolon Karseladze, International Journal of Cancer Somatic VariantHealth SciencesTumor HeterogeneityChromosome RegionsGenetics	1999	30

Page 1